Read More

L3Harris Details Financial Objectives And Value Creation Strategy At 2023 Investor Day; Presented Medium-Term Financial Framework Based On The Company’s Current Portfolio, Through 2026: $23B In Revenue, 16% Segment Operating Margins, $2.8B Free Cash Fl…

Presents Medium-Term Financial Objectives Targeting Free Cash Flow Growth and Margin ExpansionCapital Deployment Framework to Return All Excess Cash to Shareholders After Achieving Leverage Target By the End of

LHX

Read More

Ligand Holds Investor And Analyst Day; Provides Update On Portfolio Progress And Recent Transactions; Introduces 2024 Guidance; Sees FY24 EPS $4.25-$4.75 Vs $4.17 Est.; Revenue $130M-$142M Vs $138.6M Est.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) hosted anInvestor and Analyst Day in New York City earlier today. CEO Todd Davis and other members of Ligand's senior management team provided an overview of the

LGND

Read More

Grocery Outlet Holding Announces CFO Transition And Reaffirms Q4 Outlook And Fiscal 2023 Guidance; Charles Bracher Has Informed The Company Of His Intention To Step Down As CFO, Effective As Of March 1, 2024, Co Will Commence A Search For Its Next CFO

Grocery Outlet Holding Corp. (NASDAQ:GO) ("Grocery Outlet" or the "Company") today announced that Charles Bracher has informed the Company of his intention to step down as Chief Financial Officer, effective as of March

GO

Read More

MaxCyte Announces CEO Transition; Doug Doerfler, President And CEO, To Retire, Maher Masoud To Succeed, Effective Jan 1, 2024; Reiterating 2023 Core Revenue Guidance Of $28M-$30M Vs $35M Est. Expects To Exceed Prior SPL Program-Related Guidance Of $10M

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel, to Succeed Mr.

MXCT